FAKTOR-OPTIONSSCHEIN - AMGEN | Market Closed - Börse Stuttgart 02:54:39 2024-05-09 pm EDT | ||
| 5.68 EUR | -8.53% |
|
| Current month | -40.96% | ||
| 1 month | -44.26% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-09 | 5.68 | -8.53% | 0 |
| 24-05-08 | 6.21 | -5.05% | 0 |
| 24-05-07 | 6.54 | -0.91% | 0 |
| 24-05-06 | 6.6 | +7.32% | 0 |
| 24-05-03 | 6.15 | -33.66% | 0 |
Delayed Quote Börse Stuttgart
Last update May 09, 2024 at 02:54 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Morgan Stanley |
| WKN | MG0M89 |
| ISIN | DE000MG0M897 |
| Date issued | 2024-03-21 |
| Strike | 409.8 $ |
| Maturity | Unlimited |
| Parity | 15.65 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.14 € |
|---|---|
| Lowest since issue | 5.16 € |
| Spread | 0.02 € |
| Spread % | 0.35% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
307.3
USD
Average target price
313.3
USD
Spread / Average Target
+1.95%
- Stock Market
- Certificates
- Certificat